OBJECTIVE: Transplantation of skeletal myogenic precursor cells (mpc) into the myocardium using a non-surgical procedure. METHODS: Closed-chest mpc transplantation was assessed in pigs using the NOGA-Biosense device allowing both electromechanical mapping of the left ventricle (LV), and guided mpc injections through endocardium. RESULTS: We successively established that: (1) adequate preimplantation handling of mpc can be achieved when mpc are kept in 0.1% serum albumin-containing medium until implantation; (2) mpc are neither retained nor destroyed in the catheter or the needle and their passage does not affect their survival, growth and differentiation; (3) large numbers of autologous mpc can be actually transplanted in the LV myocardium by transendocardial route, as assessed by post-mortem examination of pigs injected with iron-loaded mpc; (4) cell injection into the myocardium does not induce conspicuous cell mortality since more than 80% of mpc recovered from LV tissue are alive 15 min after injection; (5) mpc injections can be guided into circumscribed LV targets such as infarcted areas, as assessed by comparison of map injection sites with location of iron-loaded mpc at post-mortem examination of LV myocardium. CONCLUSION: This new approach may pave the way for a large spectrum of cell therapies targeting myocardial diseases.
OBJECTIVE: Transplantation of skeletal myogenic precursor cells (mpc) into the myocardium using a non-surgical procedure. METHODS: Closed-chest mpc transplantation was assessed in pigs using the NOGA-Biosense device allowing both electromechanical mapping of the left ventricle (LV), and guided mpc injections through endocardium. RESULTS: We successively established that: (1) adequate preimplantation handling of mpc can be achieved when mpc are kept in 0.1% serum albumin-containing medium until implantation; (2) mpc are neither retained nor destroyed in the catheter or the needle and their passage does not affect their survival, growth and differentiation; (3) large numbers of autologous mpc can be actually transplanted in the LV myocardium by transendocardial route, as assessed by post-mortem examination of pigs injected with iron-loaded mpc; (4) cell injection into the myocardium does not induce conspicuous cell mortality since more than 80% of mpc recovered from LV tissue are alive 15 min after injection; (5) mpc injections can be guided into circumscribed LV targets such as infarcted areas, as assessed by comparison of map injection sites with location of iron-loaded mpc at post-mortem examination of LV myocardium. CONCLUSION: This new approach may pave the way for a large spectrum of cell therapies targeting myocardial diseases.
Authors: Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley Journal: J Cardiovasc Transl Res Date: 2009-10-23 Impact factor: 4.132
Authors: Ranil de Silva; Luis F Gutiérrez; Amish N Raval; Elliot R McVeigh; Cengizhan Ozturk; Robert J Lederman Journal: Circulation Date: 2006-11-13 Impact factor: 29.690
Authors: Andrey A Karpov; Yulia K Uspenskaya; Sarkis M Minasian; Maxim V Puzanov; Renata I Dmitrieva; Anna A Bilibina; Sergey V Anisimov; Michael M Galagudza Journal: Int J Exp Pathol Date: 2013-04-08 Impact factor: 1.925